If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Board Appointment

2 Feb 2009 11:01

RNS Number : 6266M
Plant Health Care PLC
02 February 2009
 



02 February 2009

Plant Health Care plc

("Plant Health Care" or "the Company")

NEW BOARD APPOINTMENT

Plant Health Care (AIM: PHC.L), a leading provider of natural products to the agriculture and landscape industries, announces that Dr. Dominik Koechlin was appointed to its Board as a non-executive director on 30 January 2009.

Dr. Koechlin, 50, a Swiss national, graduated from the University of Berne with a doctorate in law. He also has an MBA from INSEAD, Fontainebleau, France. Dr. Koechlin is currently a non-executive director of LGT Bank in Liechtenstein, and the following Swiss-listed companies: EGL AG, Swissmetal AG and Clariant AG.

Dr. Koechlin began his career working at Bank Sarasin in Basel from 1986 to 1988. He founded Ellipson AG in 1990, a business and management consultancy specialised in environmentally sound management and corporate financing. From 1996, he was a member of the executive committee of Telecom PTT and Swisscom AG.

During his time at Swisscom, the leading telecommunications provider in Switzerland, Dr. Koechlin was responsible for the redesign of the Swisscom business model, preparation for the IPO of Swisscom and development and communication of corporate strategy, as well as the international participations of Swisscom. Since 2001, Dr. Koechlin has worked as an independent board member and consultant for a number of listed and private businesses.

Dr. Albert Fischer, Non-executive Chairman of Plant Health Care commented:: "Dr. Koechlin has a great deal of experience in advising profitable, high-growth listed companies and will be a very strong addition to the Plant Health Care Board."

There is no other information that is required to be disclosed pursuant to Schedule 2 paragraph (g) of the AIM Rules, save as set out below:

Dominik Koechlin

Current Directorships

Past Directorships within last 5 years

LGT Bank in Liechtenstein Limited

Crucell NV

Elektrizitäts-Gesellschaft Laufenburg AG

Sustainable Asset Management AG

Swissmetal AG

Berna Biotech AG

Clariant AG

Novavox AG

Avaloq AG

Hesperion AG

M2 AG

Corris AG

- ends -

For further information:

John Brady

Evolution Securities Limited

Tavistock Communications

Chief Executive

Tim Worlledge/Tim Redfern

Jeremy Carey/Simon Compton

Tel: 001 603 525 3702

Tel: 020 7071 4300

Tel: 020 7920 3150

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAILFEIFAIFIIA
Date   Source Headline
12th Nov 20193:56 pmRNSHolding(s) in Company
6th Nov 201912:57 pmRNSInvestment in Company by Ospraie Ag Science LLC
30th Oct 20197:00 amRNSAppointment of new Board Directors
3rd Oct 20192:50 pmRNSDirector/PDMR Shareholding
30th Sep 20197:00 amRNSInterim Report ended 30 June 2019
9th Sep 20197:00 amRNSPilot production of PREtec peptides
19th Aug 20197:00 amRNSBlock listing Interim Review
15th Aug 20197:00 amRNSProgress with PREtec field trials in Brazil
5th Aug 20195:18 pmRNSHolding(s) in Company
25th Jun 20197:00 amRNSNew Distribution Agreement with Wilbur-Ellis
12th Jun 201911:05 amRNSResult of AGM
30th Apr 20194:19 pmRNSAnnual Report & Accounts and AGM Notice Published
10th Apr 20197:00 amRNSResults for the year ended 31 December 2018
27th Mar 20193:41 pmRNSHolding(s) in Company
28th Feb 20197:00 amRNSNew Technology Update
19th Feb 20197:00 amRNSBlock listing Interim Review
29th Jan 20197:00 amRNSTrading Statement
24th Jan 20195:58 pmRNSHolding(s) in Company
21st Dec 20187:00 amRNSTrading Statement
28th Nov 20187:00 amRNSNew Technology Update
21st Nov 20187:00 amRNSPlant Health Care ProAct® Wins Top Industry Award
19th Nov 20187:00 amRNSPlant Health Care to present at Mello London
14th Nov 20187:00 amRNSPositive Developments with Harpin
8th Nov 20187:00 amRNSChange of Adviser
5th Nov 20187:00 amRNSHolding(s) in Company
18th Sep 20187:00 amRNSInterim Report ended 30 June 2018
12th Sep 20187:00 amRNSUS Announces Harpin aß Product Launch in Corn
20th Aug 20187:00 amRNSBlock listing Interim Review
30th Jul 20187:00 amRNSUpdate on sugarcane in Brazil
16th Jul 20187:00 amRNSTrading Statement
6th Jun 20182:39 pmRNSHolding(s) in Company
6th Jun 201811:14 amRNSResult of AGM
30th May 20187:00 amRNSGrant of Options
4th May 20185:59 pmRNSHolding(s) in Company
30th Apr 20183:11 pmRNSPublication of Annual Report and Notice of AGM
10th Apr 20187:00 amRNSResults for the year ended 31 December 2017
8th Mar 20187:00 amRNSBlock listing Interim Review
7th Mar 20183:07 pmRNSHolding(s) in Company
7th Mar 20183:06 pmRNSHolding(s) in Company
7th Mar 20183:02 pmRNSHolding(s) in Company
2nd Mar 20185:48 pmRNSHolding(s) in Company
27th Feb 20184:12 pmRNSResult of Placing and Subscription
27th Feb 20187:00 amRNSProposed Placing and Subscription
24th Jan 20187:00 amRNSTrading Statement
12th Dec 20177:00 amRNSNew Technology Update
8th Dec 20174:35 pmRNSPrice Monitoring Extension
6th Dec 20174:40 pmRNSSecond Price Monitoring Extn
6th Dec 20174:35 pmRNSPrice Monitoring Extension
18th Sep 20177:00 amRNSHalf-year Report
21st Aug 20177:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.